UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Simplify your finances with user-friendly finance management tools. These resources will help you stay organized and in control of your money.
22,433 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Escrow audits are back in focus as regulators tighten oversight. Title agencies are adopting a formal escrow audit re...
Bitcoin ETFs pulled about $2 billion in net inflows in April, the strongest monthly total so far this year. May opene...
XRP trades in a tight band around $1.40 as traders weigh regulatory progress, ETF flows, and Bitcoin momentum. This r...
Newly listed THYP and BHYP tracking Hyperliquid's HYPE token post unusual first-week momentum, with sizable inflows a...
SpaceX unveiled a century long strategy spanning launches, Starlink, and AI, pushing the company toward a potential $...
A global study of family-owned businesses finds performance typically falters for five years after leadership handoff...
As tax rules and market conditions shift in 2026, retirees with $2M in retirement accounts seek to preserve wealth. T...
May delivered a sharp reversal for Bitcoin ETFs, with the biggest weekly outflows since January as risk-off trading s...
As the calendar flips to May, many investors rethink risk. This guide shows three cryptocurrencies to unload before s...
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Binance founder Changpeng Zhao addresses social media chatter claiming a Dubai surfing accident, calling the reports ...